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Primary care physicians often encounter patients with fever of unknown origin and without apparent 
causes.  Recent advances in laboratory medicine have facilitated diagnostic procedures; however,  it is 
still diﬃcult to determine the critical febrile factor at an early stage.  We reviewed the medical records 
of 174 patients who were admitted due to a chief complaint of fever (＞37.5℃) to our hospital during 
the period from 2004 to 2010.  The patients were categorized into patients with infection,  inﬂammation,  
neoplasm and drug-induced fever.  Based on the analysis done by category,  it was revealed that the 
patientʼs age,  body temperature and duration of fever were closely related to the ﬁnal diagnosis.  
Serum CRP levels were signiﬁcantly low in the nonbacterial infection group,  while serum levels of 
sIL-2R were high in neoplasm and drug-induced cases.  CRP level on admission was weakly but signiﬁ-
cantly correlated with body temperature,  while duration of fever was inversely related to body tem-
perature.  The eﬀectiveness of PET-CT and tissue biopsy for diagnosis was considerably high,  par-
ticularly in the categories of neoplasm and nonspeciﬁc inﬂammation,  respectively,  though the 
eﬀectiveness of bacterial culture was low.  Thus,  a careful review of physical and laboratory infor-
mation including body temperature,  CRP level,  duration of fever,  gender diﬀerence and history of 
medication is indispensable for diagnosis.  Stepwise categorization and disease classiﬁcation by com-
prehensive and systemic checkup are very helpful for determining the causes of fever.
Key words: computed tomography (CT),  C-reactive protein (CRP), ﬂuorodeoxyglucose positron emission 
tomography (FDG-PET),  fever of unknown origin (FUO),  soluble interleukin-2 receptor (sIL-2R)
espite recent advances in diagnostic tools,  fever 
of unknown origin (FUO) remains a crucial 
clinical problem [1-5].  Although general practitio-
ners occasionally encounter patients with FUO,  
determining the cause of FUO remains a challenge in 
clinical practice.  When further assessment is required 
in the diagnostic process,  specialists in infectious 
diseases,  rheumatologists,  hematologists and endocri-
nologists are often consulted [6].
　 In 1961,  Petersdorf and Beeson ﬁrst provided the 
classical deﬁnition of FUO as a prolonged febrile ill-
ness of at least 3-week duration,  with fever higher 
than 38.3℃ on several occasions,  the cause of which 
is uncertain after 1 week of hospitalization and inves-
tigation [7].  In 1991,  Durack and Street proposed 2 
revisions of the deﬁnition [8].  The ﬁrst change 
included classiﬁcations other than classical FUO,  
including nosocomial,  neutropenic and HIV-associated 
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FUOs.  Secondly,  the original restriction of the inpa-
tient setting was modiﬁed to at least a 3-day hospital-
ization or 3 hospital visits for evaluating a febrile 
outpatient [8,  9].
　 For the diagnosis of FUO,  an initial workup 
including complete and repeated history taking,  
physical examination,  and obligatory investigations is 
an important process known as obtaining potentially 
diagnostic clues (PDCs) [5,  10].  PDCs are deﬁned 
as all localizing signs,  symptoms,  and abnormalities 
potentially pointing to a diagnosis [11,  12].  Obtaining 
PDCs makes possible the diﬀerential diagnosis of a 
variety of possible causes of the fever.  This process 
can also simplify further diagnostic procedures and 
limit a broad spectrum of possible diseases underlying 
FUO by ruling out less likely causes.
　 The currently used criteria for FUO were pro-
posed more than 50 years ago.  There have been many 
arguments that the criteria should be altered in accor-
dance with changes in state-of-the-art medicine [1,  2,  
13-16].  Since FUO is a very complicated category,  
there is no absolute algorithm that reliably leads to a 
ﬁnal diagnosis or completely excludes particular diag-
noses.  General and/or primary care physicians must 
rely on very careful evaluation and detailed knowledge 
of a wide variety of diseases.  The deﬁnition of FUO 
may also be carefully reconsidered depending on the 
patientʼs social,  regional and medical background.  In 
this regard,  a recent report by Goto and colleagues 
may ﬁt our current process for handling and diagnos-
ing Japanese febrile patients [17].  They reported 
results of a retrospective study on hospitalized patients 
with fever in addition to classical FUO [17].  Based 
on their including a wide range of 226 febrile patients 
with axillar temperature ＞37℃,  they concluded that 
strict use of the FUO deﬁnition is not always war-
ranted when managing patients with prolonged fever.
　 Considering the background regarding FUO han-
dling in Japanese medical institutes,  we performed a 
systematic review of the medical records of 174 
patients who were admitted due to persistent fever 
(＞37.5℃) to our university hospital during a 7-year 
period from 2004 to 2010.  Patients who did not 
completely match the classic criteria of FUO were also 
included in the present study.  The patients were cat-
egorized into infection,  inﬂammation,  neoplasm and 
drug-induced fever groups.  The clinical details of 
febrile patients in Okayama district were character-
ized in this study.  An analysis of sub-classiﬁed cate-
gories revealed that initial clinical signs and conven-
tional laboratory markers are very useful for achieving 
diagnosis in febrile patients at an early stage.
Subjects and Methods
　 Study subjects. We retrospectively reviewed 
the medical records of 174 febrile patients who were 
admitted to Okayama University Hospital during the 
period from Jan 2004 to Dec 2010 for the purpose of 
diagnosing the cause of a fever.  Patients who were 
admitted due to a chief complaint of persistent fever,  
with an axillary temperature ＞37.5℃,  were incorpo-
rated.  The patients included 82 males (47ｵ) and 92 
females (53ｵ),  and the mean age on admission was 
48.4 years (range: 15 to 92 years).  Of the 174 patients,  
146 (84ｵ) had visited a city hospital and/or medical 
care clinic at least once.  One hundred and twenty-
seven (73ｵ) of the patients were referred with docu-
ments and 44 (25ｵ) of the patients were already 
hospitalized in the former medical institute(s).  This 
protocol of the present study (No. 1496) was approved 
by the Institutional Review Board (IRB) of Okayama 
University Graduate School of Medicine,  Dentistry 
and Pharmaceutical Sciences.
　 Laboratory examination and histological 
approach. White blood cell counts and serum 
C-reactive protein (CRP) levels were determined by an 
auto-analyzer system in the Central Laboratory of 
Okayama University Hospital.  Serum CRP levels 
were determined by a latex-agglutination method using 
latex particles conjugated with anti-CRP antiserum,  
and the normal range was ＜0.3mg/dl.  Serum soluble 
interleukin-2 receptor (sIL-2R) levels were deter-
mined by an enzyme-linked immuno-sorbent assay using 
the IL-2R test － BML kit (BML,  Tokyo),  and the 
normal range was 122 to 496U/ml.  Tissue biopsies 
were performed for 55 febrile patients,  and the 
regions of the biopsy included a total of 63 locations,  
including 30 biopsies in bone marrow,  19 in lymph 
nodes,  7 in skin/muscle,  3 in tumors,  and 1 in a ves-
sel and other symptom-related tissues such as the 
small intestine,  spleen and kidney.
　 Scoring of the eﬀectiveness of clinical exami-
nations for diagnosis. Based on its clinical use-
fulness and contribution to the ﬁnal diagnosis of FUO,  
each of the clinical examinations,  including computed 
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tomography (CT) scan (plain and enhanced study),  
scintigraphy (including 67Ga-scintigraphy),  [18F] ﬂuo-
rodeoxyglucose positron emission tomography (FDG/
PET)-CT,  biopsy,  bacterial culture and 
QuantiFERON-TB test (QFT),  was scored by at least 
three physicians in a daily clinical conference in our 
department as follows: not useful result＝0 points;  
useful result for diﬀerential diagnosis＝1 point; and 
directly diagnostic result＝2 points (full score).  The 
percent eﬀectiveness was calculated as the percentage 
of points obtained out of the total possible scores of 
individual examinations.
　 Statistical analysis. Results are shown as 
means ± SEM of the data.  The data were subjected 
to ANOVA and a linear regression analysis to deter-
mine diﬀerences (StatView 5.0 software,  Abacus 
Concepts,  Inc.,  Berkeley,  CA,  USA).  If diﬀerences 
were detected by ANOVA,  Tukey‒Kramerʼs post-hoc 
test was used to determine which means diﬀered.  P 
values ＜0.05 were accepted as statistically signiﬁcant.
Results
　 Categorization of the study population. As 
shown in Fig.  1A,  the patients included in this study 
were categorized according to the diagnosis of the 
deﬁned cause as follows: infection (41.4ｵ),  inﬂamma-
tion (27ｵ),  neoplasm (6.9ｵ) and drug-induced fever 
(5.7ｵ).  For the remaining 33 cases (19ｵ),  no ﬁnal 
diagnosis for FUO was determined,  although the fever 
remitted spontaneously in all of those cases.  The 5 
categories were further classiﬁed into 7 subgroups 
including bacterial and non-bacterial infection,  non-
speciﬁc inﬂammation,  connective-tissue diseases,  
neoplasm,  drug-induced and unidentiﬁed cases.  The 
female/male ratio was high (＞60ｵ) in the categories 
of connective-tissue diseases and nonspeciﬁc inﬂamma-
tion (Fig.  1B).  On the other hand,  the male/female 
ratio (＞60ｵ) was high in drug-induced fever and 
unidentiﬁed fever.
　 Characterization of disease category. In the 
category of bacterial infection (Fig.  2A),  the sources 
were classiﬁed by frequency as follows: urinary tract 
(17ｵ)＞cardiovascular system and abdominal cavity 
(10ｵ)＞respiratory system,  head and neck,  and 
sepsis (7ｵ).  Other sources included the prostate,  
lymph nodes,  intestine and deep subcutaneous tissues.  
For non-bacterial infection (Fig.  2B),  infections due 
to cytomegalovirus (CMV; 34ｵ) and Epstein-Barr 
virus (EBV; 15ｵ) were predominant,  followed by 
infections due to viral meningitis (12ｵ) and lymph-
adenitis (9ｵ).  Fungal infection was diagnosed in 2 
cases (2.8ｵ of the 72 infection-categorized cases).  
For the inﬂammation category,  the major causes 
included connective-tissue diseases (21 cases) and 
nonspeciﬁc inﬂammation (26 cases).  As shown in Fig.  
3A,  adult onset Stillʼs disease (AOSD; 33ｵ),  poly-
myalgia rheumatica (PMR; 20ｵ) and Behcetʼs disease 
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Fig. 1　 Categorization of febrile patients.  A,  The 174 febrile patients were categorized into patients with infection (41.4%),  inﬂamma-
tion (27%),  neoplasm (6.9%),  drug-induced fever (5.7%) and fever of unidentiﬁed cause (19%); B,  These 5 categories were further classi-
ﬁed into 7 subgroups including bacterial and non-bacterial infection cases,  nonspeciﬁc inﬂammation and connective-tissue disease cases,  
neoplasm cases,  drug-induced cases and unidentiﬁed cases. The female/male ratios are shown in the graphs.
(13ｵ) were the major causes of fever,  followed by 
polymyositis,  remitting seronegative symmetrical 
synovitis with pitting edema (RS3PE; 7ｵ) and sys-
temic lupus erythematosus (SLE; 7ｵ).  As seen in 
Fig.  3B,  nonspeciﬁc inﬂammation (26 cases) included 
many cases of necrotizing lymphadenitis (38ｵ),  and 
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Fig. 2　 Characterization of infection category.  A,  Breakdown of 41 bacterial infection cases with fever.  The detected infection sources 
were as follows: urinary tract (17%)＞cardiovascular system and abdominal cavity (10%)＞ respiratory system,  head and neck,  and sepsis 
(7%)＞prostate,  lymph nodes and intestine (5%)＞deep tissues (3%); B,  Breakdown of 31 non-bacterial infection cases with fever.  CMV 
(34%) and EBV (15%) infection were predominant,  being followed by viral meningitis (12%),  lymphadenitis (9%) and viral enterocolitis 
(3%).  Fungal infection occurred in only 2 cases (2.8% of the 72 infection-categorized cases).
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Fig. 3　 Characterization of inﬂammation and neoplasm categories.  A,  Breakdown of 21 connective-tissue diseases with fever.  AOSD 
(33%),  PMR (20%) and,  less frequently,  Behcetʼs disease (13%) were the major causes of FUO,  followed by polymyositis (7%),  R3SPE 
(7%) and SLE (7%); B,  Breakdown of 26 nonspeciﬁc inﬂammation cases with fever.  This group included many cases of necrotizing 
lymphadenitis (38%),  and the remaining cases were pseudogout (11%),  connective tissue inﬂammation (11%),  erythema nodosum (8%) 
and thyroiditis (8%).  Other minor (4%) causes were RPGN,  interstitial pneumonia,  Crohnʼs disease,  pericarditis,  pulmonary infarction and 
sarcoidosis; C,  Breakdown of 12 neoplasm cases with fever.  This group predominantly included malignant lymphoma (50%),  metastatic 
cancer (17%) and leukemia (17%) and,  less frequently,  rectal cancer (8%) and intra-peritoneal tumor (8%).
the remaining cases were pseudogout (11ｵ),  connec-
tive tissue inﬂammation (11ｵ),  and erythema nodosum 
and thyroiditis (8ｵ each).  Other minor (4ｵ) causes 
were rapidly progressive glomerulonephritis (RPGN),  
interstitial pneumonia,  Crohnʼs disease,  pericarditis,  
pulmonary infarction and sarcoidosis.  Fig.  3C shows 
the category of neoplasms (12 cases),  including pre-
dominantly malignant lymphoma (50ｵ),  metastatic 
cancer (17ｵ),  leukemia (17ｵ),  rectal cancer (8ｵ) 
and intraperitoneal tumor (8ｵ).
　 Interrelationships between body temperature 
and clinical parameters. Correlations of body 
temperature with conventional parameters including 
WBC,  serum levels of CRP and sIL-2R,  and duration 
of fever were determined by linear regression analy-
sis.  As shown in Fig.  4,  among the 4 parameters,  
CRP level on admission was weakly but signiﬁcantly 
(R2＝0.10,  p＜0.01) correlated with body tempera-
ture.  Duration of fever was inversely related to body 
temperature (R2＝0.06,  p＜0.05).  The values of WBC 
and sIL-2R were not signiﬁcantly related to the degree 
of the fever.
　 Clinical characteristics of sub-classiﬁed 
groups. Age,  body temperature and duration of 
fever in the 7 subgroups were compared.  As shown in 
Fig.  5,  the average age of patients suﬀering non-
bacterial infection was signiﬁcantly younger (34.7 
years old) than the average ages of patients in the 
other subgroups.  It is notable that the degrees of 
fever in patients in the subgroups of nonbacterial 
infection,  connective-tissue diseases and unidentiﬁed 
cases were signiﬁcantly lower (＜38℃) than those in 
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Fig. 4　 Interrelationships of body temperature with clinical parameters.  Correlations between body temperature and clinical parameters,  
including WBC,  CRP and sIL-2R,  and duration of fever were determined by linear regression analysis.  Among the 4 parameters,  CRP level 
on admission was weakly (R2＝0.10) but signiﬁcantly (p＜0.01) correlated with body temperature.  Duration of fever was inversely related 
to body temperature (R2＝0.05; p＜0.01).
patients in the other 4 subgroups (＞38℃).  The 
durations of fever were longer in patients with con-
nective-tissue diseases and neoplasms,  lasting for 
almost 2 months (55-57 days).  The unidentiﬁed cases 
also had a much longer duration of fever,  lasting for 
more than 6 months (132 days).
　 Laboratory data of sub-classiﬁed groups.
WBC,  CRP and sIL-2R levels in the 7 subgroups 
were compared (Fig.  6).  WBC levels were signiﬁ-
cantly lower (＜8,000/µl) in the subgroups of nonbac-
terial infection and nonspeciﬁc inﬂammation than in the 
other 5 groups.  CRP levels were also signiﬁcantly 
lower in the nonbacterial infection subgroup (＜1.5mg/ 
dl) and the subgroup of unidentiﬁed cases (＜4mg/dl).  
The serum levels of sIL-2R were signiﬁcantly higher 
in patients with neoplasms (＞3,000U/ml) and,  inter-
estingly,  in drug-induced cases (＞2,000U/ml).
　 Eﬀectiveness of clinical examinations for 
diagnosis. Clinical examinations included 150 CT 
scans (63 plain and 87 enhanced studies),  52 scintig-
raphy examinations (including 48 cases of 
67Ga-scintigraphy),  29 FDG/PET-CT scans,  tissue 
biopsies of 63 specimens in 55 cases (biopsies from 
more than 1 tissue being performed in 8 patients),  
130 bacterial cultures and 39 QFT assays (Fig.  7A).  
CT scans (86ｵ of patients) and bacterial cultures 
(75ｵ) were most frequently performed in the process 
of diagnosis.  Among the 130 bacterial cultures,  causal 
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Fig. 5　 Clinical diﬀerences among subclassiﬁed febrile groups.  
Among the 7 subgroups,  patientʼs age (years),  body temperature 
(℃) and duration of fever (days) were statistically analyzed.  The 
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results were analyzed by ANOVA and,  when a signiﬁcant eﬀect was 
observed,  subsequent comparisons of group means were con-
ducted.  ＊p＜0.05 and ＊＊p＜0.01 vs. control or between the indi-
cated groups.
bacteria were positively detected in 16 cases (12ｵ) 
(Fig.  7B).  The causal bacteria included E. coli (25ｵ),  
Streptococcus (25ｵ),  Staphylococcus (19ｵ) and 
Campylobacter (7ｵ).  The sample sources were pre-
dominantly from blood cultures (65ｵ) and urine 
(17ｵ) and less often from pus (12ｵ) and cerebrospi-
nal ﬂuid (CSF; 6ｵ).  As shown in Fig.  7C,  ｵeﬀec-
tiveness as determined by CT scan (plain as well as 
enhanced study) and scintigraphy was found to be 
approximately ～30ｵ,  whereas that determined by 
PET-CT (51.7ｵ) and that determined by biopsy 
(63.6ｵ) were found to be considerably higher.  In 
contrast,  the eﬀectiveness of bacterial culture was 
unexpectedly low (12.3ｵ in all cases and 28.1ｵ in 
infection-category cases).  The eﬀectiveness of QFT 
for the diagnosis of the febrile cause was relatively 
low (15.4ｵ).
　 Scoring of eﬀectiveness by PET-CT and 
biopsy for diagnosis. The cases that underwent 
PET-CT and biopsies are shown in Fig.  8.  PET-CT 
examination was performed when connective-tissue 
disease and neoplasm were clinically suspected for the 
etiology of the fever,  and PET-CT was the most 
eﬀective method for the detection of neoplasms (Fig.  
8A).  Tissue biopsies were often performed for diag-
nosis and/or to rule out the categories of nonspeciﬁc 
inﬂammation,  neoplasm,  unidentiﬁed cases and con-
nective-tissue diseases (Fig.  8A).  For the diagnosis of 
the infection category,  PET-CT and biopsy studies 
were the least often carried out.  As shown in Fig.  
8B,  biopsy studies for bone marrow (30 cases),  lymph 
nodes (19 cases) and skin/muscle (7 cases) were the 
most-often performed,  with lymph-node biopsies being 
applicable to the diagnosis of the category of nonspe-
ciﬁc inﬂammation and with bone marrow and tumor 
specimens being informative for determining the exis-
tence of a neoplasm.
Discussion
　 In the present study,  we reviewed the medical 
records of 174 patients who were admitted to our 
hospital due to persistent fever (＞37.5℃) during a 
7-year period.  The patients were categorized into 5 
groups including infection,  inﬂammation,  neoplasm,  
drug-induced fever and unidentiﬁed fever groups (Fig.  
9).  Further classiﬁcation into 7 groups revealed 
physical and laboratory characteristics depending on 
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Fig. 7　 Eﬀectiveness of clinical examinations for the diagnosis of 
the cause of a fever.  A,  Clinical examinations performed in the 
present study included 150 CT scans (63 plain and 87 enhanced 
studies),  52 scintigraphy examinations (including 48 cases of 
67Ga-scintigraphy),  29 FDG/PET-CT scans,  55 biopsy cases,  130 
bacterial cultures (57 cases included in the infection category) and 
39 QFT examinations; B,  Breakdown of detected bacteria: Out of 
130 bacterial cultures,  causal bacteria including E. coli,  
Streptococcus,  Staphylococcus and Campylobacter were detected 
in 16 cases.  The samples were from blood and urine samples and,  
less often,  from pus and CSF; C,  Evaluation of the eﬀectiveness 
of examinations by “eﬀective scoring”.  Based on the relative use-
fulness and contribution to the ﬁnal diagnosis of fever,  eﬀective 
scoring was utilized.  The eﬀectiveness was ～30% (shown by a 
dotted line) for CT scan (total,  plain and enhanced),  scintigraphy 
(total),  67Ga-scintigraphy and bacterial culture (of infection cases),  
which was lower than the eﬀectiveness of 50% for PET-CT and 
biopsy,  and higher than the eﬀectiveness of 20% for bacterial cul-
ture (of all cases) and QFT.
the causes of fever.
　 The 5 major categories of febrile causes were 
established according to previous reports [7,  11-14,  
18,  19].  In comparison with our data,  the percent-
ages of the 3 major categories of FUO,  infection 
(41ｵ in the present study vs. 25-36ｵ in the litera-
ture),  tumor (6.9ｵ vs. 7-31ｵ) and collagen vascular 
and granulomatous diseases (27ｵ vs. 17-26ｵ),  
remained almost unchanged throughout several FUO 
studies performed in diﬀerent periods [20].  Iikuni et 
al.  analyzed the causes of FUO in 153 Japanese 
patients in a university hospital from 1982 to 1992 
[21] and found that infection and neoplasm were the 
most frequent causes of fever.  According to a study 
of 80 FUO patients in the Shinetsu area in 1986-
1992 by Shoji et al.  [22],  the number of neoplasm-
induced FUO cases decreased,  while the number of 
FUO cases related to connective-tissue diseases such 
as AOSD increased.  These trends were similar to 
those in our study,  resulting in a relatively low rate 
of malignancy (6.9ｵ of total cases) and high frequen-
cies of AOSD and PMR (33ｵ and 20ｵ of connec-
tive-tissue diseases,  respectively).
　 Recent developments in radiological techniques 
such as FDG-PET has greatly improved the ability to 
diagnose occult malignancies and origins of inﬂamma-
tion [10,  23].  Increased uptake and retention of FDG 
are shown in lesions with a high concentration of 
granulocytes and activated macrophages in acute and 
chronic inﬂammation [24].  The diagnostic usefulness 
of FDG-PET for patients with FUO was reported to 
be 36ｵ [25].  We have been utilizing FDG-PET for 
febrile patients since 2007,  with a diagnosis being 
made in 9 of 28 febrile patients who underwent FDG-
PET.  FDG-PET was more useful (51.7ｵ of patients) 
than 67Ga-scintigraphy (31.2ｵ) for diagnosing malig-
nant lymphoma and metastatic cancers as causes of 
fever.  However,  we cannot exclude the possibility of 
selection bias in the diagnosis of the cause of fever 
using PET-CT.
　 After the localization of a febrile source,  biopsy is 
often required to pathologically diagnose its inﬂamma-
tory or neoplastic origin.  In the present series of 55 
biopsies,  biopsy examination was diagnostically useful 
in 44 cases,  resulting in a 63.6ｵ rate of eﬀective-
ness,  which was higher than that of FDG-PET 
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Fig. 8　 Details of PET-CT and biopsy for diagnosis of febrile cause.  A,  Eﬀective scoring of PET-CT and tissue biopsies in each cate-
gory.  FDG/PET-CT scans in 29 cases and 63 tissue biopsies in 55 cases were performed.  The numbers of patients with eﬀective scoring 
(0 to 2 points) in the 7 febrile categories are shown in each graph; B,  Study number of tissue biopsies in each category: 63 tissue biop-
sies in 55 cases were performed.  The numbers of examined tissues including bone marrow,  lymph nodes,  skin/muscle,  vessels,  tumors 
and others are shown on the basis of the 7 febrile categories.
(51.7ｵ).  The pathology of biopsy specimens from 
bone marrow,  lymph nodes and skin/muscle was cru-
cial for the diagnosis of fever.  Lymph node specimens 
were useful for the category of nonspeciﬁc inﬂamma-
tion,  and bone marrow and tumor specimens were 
diagnostic for neoplasms.  Thus,  biopsy was found to 
be very eﬀective for determining febrile diseases after 
an adequate search for the localization.  When infec-
tion etiology is excluded from the causes of fever,  
combined PET-CT and biopsy examinations may 
eﬀectively cover 3 febrile categories including nonspe-
ciﬁc inﬂammation,  connective-tissue disease and neo-
plasm.
　 Regarding the miscellaneous causes of FUO,  the 
possibility of drug-induced fever should always be 
considered [26].  Drug-induced fever occurs in 3-5ｵ 
of hospitalized patients with variable patterns of onset 
and duration [27].  In the present series,  10 febrile 
patients,  including 8 patients referred from other 
specialists,  were found to have drug-induced fever.  
Six of the 10 patients with drug-induced fever in our 
study showed slight bradycardia,  which is known to be 
a characteristic of drug-induced fever [26].  The 
causal agents included antibiotics,  non-steroidal anti-
inﬂammatory drugs (NSAIDs),  general cold medicine 
and Chinese medicine.  Four cases were detected by a 
drug-induced lymphocyte stimulation test (DLST).  In 
our cases of drug-induced fever,  the fever disappeared 
in 3 to 24 days after cessation of the administration of 
the causal drugs.  It was of interest that the body 
235Analysis of Diagnostic Clues for Febrile PatientsAugust 2013
Infection Inﬂammation
Drug-
induced
Unidentiﬁed
174 Febrile patients (>37.5℃)
Younger cases (<35yo)
Low-grade fever (<38℃)
Relatively less WBC (<8000)
Lower CRP level (<1.5)
Female dominant
Low-grade fever (<38℃)
Long-term fever (2m)
Careful history-taking
Unexpectedly high
sIL-2R (>2000)
Relative bradycardia
Long-term fever (2m)
Higher sIL-2R level (>3000)
PET-CT eﬀective
Biopsy deﬁnitive
Low-grade fever (<38℃)
Very long-term fever (4m)
Relatively low CRP (<4)
• E. coli
• Streptococcus
• Staphylococcus
• Campylobacter
• CMV
• EBV
• Meningitis
• Lymphadenitis
41 31 26 21
12
10
33
• AOSD
• PMR
• Behcet
• Polymyositis
• Lymphoma
• Metastasis
• Leukemia
• Rectal cancer
• Necrotizing
lymphadenitis
• Pseudogout
• Connective tissue
• Urinary tract
• Cardiovascular
• Abdominal
• Respiratory
Female dominant
Relatively less WBC (<8000)
PET-CT eﬀective
Biopsy deﬁnitive
4727
Bacterial-culture deﬁnitive
Connective-
tissue diseases
Stepwise categorization
Classiﬁcation
Clinical characteristics for diagnosis
Neoplasm
Nonspeciﬁc
inﬂammation
Bacterial
infection
Non-bacterial
infection
Fig. 9　 Categorization and clinical characteristics of febrile diseases.  Stepwise categorization of febrile diseases is useful for diﬀerenti-
ating various febrile disorders.  Body temperature,  CRP levels,  duration of fever and gender diﬀerences provide useful information for the 
initial narrowing of the list of possible causes of fever.  FDG-PET and biopsy study are particularly eﬀective for the diagnosis of neoplasm,  
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temperature was unexpectedly high (＞38℃) on 
admission in 6 of those 10 patients.
　 Serum sIL-2R levels have been shown to be high in 
patients with neoplastic,  autoimmune,  or inﬂamma-
tory diseases [28] and to correlate with the extent of 
histologic malignancy and clinical aggressiveness of 
non-Hodgkinʼs lymphomas [29].  In the present study,  
patients with fever due to malignant lymphomas 
showed high serum levels of sIL-2R (＞3,000U/ml).  
It was also notable that patients with drug-induced 
fever also showed increased levels of serum sIL-2R,  
though the levels were much lower (～2,000U/ml) and 
ﬂuctuated compared with neoplastic cases.  Kluge et al.  
reported a number of interesting cases in which a 
fever was induced by the antipsychotic drug clozapine 
[30].  Serum sIL-2R levels were found to be high in 
clozapine-treated febrile patients with the activation 
of cytokines and the receptors induced by the drug.
　 As for other laboratory tests in our study,  QFT 
data were partially informative for the diagnosis of 
fever.  In our series,  6 cases were positive out of the 
39 examined cases,  and only 1 case was ﬁnally diag-
nosed as tuberculosis-induced fever.  Although the 
eﬀectiveness of QFT screening was unexpectedly low 
(15ｵ of the patients),  it is important as a way to 
eliminate the possibility of occult tuberculosis in 
elderly patients and in immunodefective patients [31].  
Serum anti-HIV examination was performed in 43 
febrile cases after individual permission was given,  
with no positive case being found.  Screening for anti-
HIV antibody and/or determination of the CD4/8 
ratio are required at an early stage to exclude HIV-
associated fever [32],  although regional and social 
diﬀerences may exist in Japan.  Also,  we could not 
include data for procalcitonin (PCT) because of an 
insuﬃcient number of cases.  Plasma concentrations of 
PCT have been shown to increase more rapidly than 
CRP in patients with bacterial and fungal infections,  
whereas,  in contrast to CRP,  PCT is not elevated in 
patients with inﬂammation of a noninfectious origin 
[33].  We would like to obtain new information 
regarding FUO diagnosis using PCT screening in a 
future study.
　 The causes of FUO diﬀer depending on the patientʼs 
age [34-36].  Self-limited viral infections with high 
fever are uncommon as causes in elderly patients,  
while temporal arteritis,  tumors and tuberculosis are 
more likely in elderly patients [34].  Connective-tissue 
diseases such as temporal arteritis,  rheumatoid 
arthritis (RA) and PMR cause about 25ｵ of FUO 
cases in elderly patients,  and malignancy accounts for 
10-20ｵ of FUO cases [37,  38].  Therefore,  FUO in 
elderly patients should be deﬁned as a low-grade fever,  
such as a persistent oral or tympanic membrane tem-
perature＞37.2℃,  persistent rectal temperature 
＞37.5℃,  or an increase over the baseline tempera-
ture of＞1.3℃ [34].  In this regard,  Goto and col-
leagues reported the results of a retrospective study 
on hospitalized patients with fever in addition to clas-
sical FUO [17].  Their study included a wide range of 
226 prolonged-febrile patients with an axillar tem-
perature＞37℃.  They noted that there was a consid-
erable number of patients with critical diseases 
including intra-abdominal abscess,  sarcoidosis,  ulcer-
ative colitis,  Castlemanʼs disease,  malignancies and 
panhypopituitarism even among patients who had pro-
longed fever but did not completely meet the FUO 
deﬁnition [17].  In the present study,  we carefully 
examined patients with a body temperature＞37.5℃ 
and then diagnosed the causes of the fever.  However,  
a bias due to the physician who ﬁrst treated the 
patient might exist [3,  39].  In addition,  there were 
still 33 patients (19ｵ) with fevers of unidentiﬁed 
origin,  although the fever slowly normalized spontane-
ously in these cases.  These cases of fever might have 
included cases of factitious fever,  allergic fever or 
self-limiting inﬂammation.  Although FUO patients who 
remain undiagnosed after extensive evaluation gener-
ally have favorable outcomes [3],  careful follow-up to 
rule out malignancy,  recurrent inﬂammation or occult 
connective-tissue disease is needed.
　 Collectively,  the results of the present study sug-
gested that the categorization of febrile diseases is a 
very useful process for diﬀerentiating the original 
disorders (Fig.  9,  from the top).  Among clinical 
parameters,  body temperature,  CRP levels,  duration 
of fever and gender diﬀerences provide important 
information to narrow down the list of causes of a 
fever (Fig.  9,  from the bottom).  The exclusion of drug-
induced fever is also necessary.  FDG-PET and biopsy 
are eﬀective for the diagnosis of neoplasm and nonspe-
ciﬁc inﬂammation,  whereas bacterial culture might 
include false-negative results due to therapeutic bias.  
Stepwise categorization by means of comprehensive 
and systemic checkup is necessary for general physi-
cians in order to diagnose FUO at an early stage.
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